7 hybrid virtualization models defining pharmaceutical research in 2026 As we navigate the first quarter of 2026, the global clinical landscape has shifted decisively toward a patient-centric model that prioritizes home-based participation over traditional site visits. Regulatory bodies in the United Kingdom and the European Union have issued harmonized frameworks that mandate digital inclusion...

The eClinical solutions market is becoming an increasingly important part of modern clinical research as pharmaceutical and biotechnology companies manage larger datasets, more complex protocols, decentralized trials, and stricter regulatory requirements. The market was valued at USD 11.5 billion in 2025 and is projected to grow from USD 13.1 billion in 2026 to USD 35.1 billion by 2033,...